SLN

Companies
NASDAQ
Silence Therapeutics plc ADR
Health Care
Price Chart
Overview

About SLN

silence therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of rna interference, or rnai, within its cells. our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic rna molecules exclusively to target cells. silence’s proprietary rna chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases. for more information, visit us at www.silence-therapeutics.com

Market Cap
$955.6M
Volume
1.5M
Avg. Volume
1.2M
P/E Ratio
-1.6911764355266794
Dividend Yield
0.00%
Employees
110.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.56
Low Correlation
Volatility
High (0.83)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for SLN.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, SLN shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$955.6M
Volume1.5M
P/E Ratio-1.69
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
November 10, 2022
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how SLN fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025